-+ 0.00%
-+ 0.00%
-+ 0.00%

KNIGHT THERAPEUTICS ANNOUNCES REGULATORY SUPPLEMENTAL SUBMISSION OF MINJUVI® (TAFASITAMAB) FOR FOLLICULAR LYMPHOMA IN BRAZIL

Reuters·07/31/2025 21:11:40

Please log in to view news